- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02836535
The Patient-Perspective of Complications After Colon and Rectum Surgery: A Qualitative Analysis
June 28, 2017 updated by: Memorial Sloan Kettering Cancer Center
The purpose of this study is to understand the patient experience with an adverse event after surgery.
An adverse event is an undesirable experience or complication associated with your surgery.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Actual)
9
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
New York, New York, United States, 10065
- Memorial Sloan Kettering Cancer Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients at MSK
Description
Inclusion Criteria:
- Age 18 or older
- Patients who had elective surgery for a primary colorectal cancer within the last 90 days.
Patients who either:
- Develop an eligible complication (Appendix 1) within 30 days of surgery (n = 25 - 30)
- Do not develop any complication after surgery (n = 25 - 30)
Exclusion Criteria:
- Multivisceral resections
- Metastatic or locally-recurrent disease
- Physical impairment that may prevent participation in an interview or survey setting
- Active psychiatric illness, cognitive or sensory impairment
- Inability to speak or understand English
- Refusal to participate in an audio-recorded interview
- Inability to participate in an audio-recorded interview for reasons not otherwise specified
- Any second surgical procedure unrelated to the complication within the 90-day period
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
patients with complications
Each subject will participate in an audio-recorded interview, either in-person or by telephone, expected to last 30 to 60 minutes.
Subjects' responses to the interview questions and basic demographic data will remain confidential.
The interview will examine the impact of complications utilizing a semi-structured script specific to each group
|
|
|
patients without Complications (control group)
Each subject will participate in an audio-recorded interview, either in-person or by telephone, expected to last 30 to 60 minutes.
Subjects' responses to the interview questions and basic demographic data will remain confidential.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of complications
Time Frame: within 90 days
|
Information gathered from these interviews will form the basis for the conceptual model of surgical complications.
Qualitative data will be obtained from patients who have directly experienced a surgical complication.
These complications are defined and categorized by the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.
|
within 90 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Larissa Temple, MD, MSc, Memorial Sloan Kettering Cancer Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Helpful Links
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2016
Primary Completion (Actual)
June 28, 2017
Study Completion (Actual)
June 28, 2017
Study Registration Dates
First Submitted
July 13, 2016
First Submitted That Met QC Criteria
July 18, 2016
First Posted (Estimate)
July 19, 2016
Study Record Updates
Last Update Posted (Actual)
June 29, 2017
Last Update Submitted That Met QC Criteria
June 28, 2017
Last Verified
August 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 16-940
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Colorectal Cancer
-
University of California, San FranciscoCompletedStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedRectal Cancer | Colon Cancer | Cancer Survivor | Colorectal Adenocarcinoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
M.D. Anderson Cancer CenterRecruitingColorectal Adenocarcinoma | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage... and other conditionsUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Thomas...United States Department of DefenseActive, not recruitingColorectal Adenoma | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage 0 Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal... and other conditionsUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingStage IV Colorectal Cancer AJCC v8 | Stage IVA Colorectal Cancer AJCC v8 | Stage IVB Colorectal Cancer AJCC v8 | Stage IVC Colorectal Cancer AJCC v8 | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC... and other conditionsUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)CompletedCancer Survivor | Stage III Colorectal Cancer AJCC v8 | Stage IIIA Colorectal Cancer AJCC v8 | Stage IIIB Colorectal Cancer AJCC v8 | Stage IIIC Colorectal Cancer AJCC v8 | Stage I Colorectal Cancer AJCC v8 | Stage II Colorectal Cancer AJCC v8 | Stage IIA Colorectal Cancer AJCC v8 | Stage IIB Colorectal... and other conditionsUnited States
-
Emory UniversityBristol-Myers Squibb; National Cancer Institute (NCI); National Institutes of...CompletedColorectal Cancer Metastatic | Colorectal Adenocarcinoma | Stage IV Colorectal Cancer | Stage IVA Colorectal Cancer | Stage IVB Colorectal Cancer | Refractory Colorectal Carcinoma | Metastatic Microsatellite Stable Colorectal Carcinoma | Stage IVC Colorectal CancerUnited States
-
University of Roma La SapienzaCompletedColorectal Cancer Stage II | Colorectal Cancer Stage III | Colorectal Cancer Stage IV | Colorectal Cancer Stage 0 | Colorectal Cancer Stage IItaly
-
University of Southern CaliforniaNational Cancer Institute (NCI); AmgenTerminatedStage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | Colorectal Adenocarcinoma | RAS Wild Type | Stage III Colorectal Cancer AJCC v7 | Stage IIIA Colorectal Cancer AJCC v7 | Stage IIIB Colorectal Cancer AJCC v7 | Stage IIIC Colorectal Cancer...United States
Clinical Trials on qualitative interviews
-
University of Colorado, DenverOrthotic and Prosthetic Education and Research Foundation (OPERF)Completed
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompleted
-
Bournemouth UniversityCompletedDementia | Falls | Discharge PlanningUnited Kingdom
-
Massachusetts General HospitalCompletedStem Cell Transplant ComplicationsUnited States
-
M.D. Anderson Cancer CenterRecruitingEndometrial CancerUnited States
-
Teesside UniversityUniversity of YorkRecruitingDepression | Chronic PainUnited Kingdom
-
University of Colorado, DenverChildren's Hospital ColoradoRecruiting
-
Sichuan Cancer Hospital and Research InstituteChongqing Medical University; Wu Jieping Medical Foundation; The Third People... and other collaboratorsRecruiting
-
Royal Devon and Exeter NHS Foundation TrustKing's College Hospital NHS Trust; Portsmouth Hospitals NHS Trust; North Bristol... and other collaboratorsRecruitingBladder Cancer | Bladder Outflow ObstructionUnited Kingdom
-
Royal Marsden NHS Foundation TrustInstitute of Cancer Research, United KingdomEnrolling by invitationGenetic Predisposition to Disease | Prostate Cancer | BRCA MutationUnited Kingdom